CSI Market
Sign In | Register

Abbvie Inc (ABBV) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ABBV Annual Cash Flow →
By examining cash flow figures across successive periods, users can identify shifts in Abbvie Inc's cash generation and deployment strategy.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
9 Months 		(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Operating Activities
Income8,497.00
Depreciation & amortization574.00
Amortization of Other Assets5,106.00
Special charges0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability4,734.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories475.00
Purchased in-process R & D0.00
Gain (Loss) on Disposition of Other Assets0.00
Share-based Compensation770.00
Sharebased compensation0.00
Foreign Currency Transaction Loss, before Tax0.00
Impairment Of Intangible Assets Excluding Goodwill-
Upfront Costs Related To Collaborations-
Research And Development Asset Acquired Other Than Through Business Combination Written Off744.00
Payment For Contingent Consideration Liability Operating Activities-722.00
Income taxes0.00
Prepaid expenses0.00
Increase (Decrease) in Accounts Receivable970.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities591.00
Losses/ -gains on investments net0.00
Post-retirement benefits expense0.00
Increase (Decrease) in Prepaid Expense and Other Assets87.00
Other Working Capital0.00
Other Noncash Income (Expense)35.00
Other net7.00
Payments for (Proceeds from) Other Operating Activities-6,975.00
Discontinued operations0.00
Net Cash flow from Operating Activities14,871.00
Investing Activities
Capital Expenditures-888.00
Sale of Capital Items0.00
Short-term investments liq.0.00
Payments to Acquire Marketable Securities0.00
Proceeds from other investments0.00
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments to Acquire Other Investments-1,356.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-10,594.00
Investment in affiliate0.00
Sale of businesses0.00
Proceeds from sale of assets0.00
Restricted funds0.00
Payments for (Proceeds from) Other Investing Activities852.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-11,986.00
Financing Activities
Short-term debt Net-2,499.00
Other borrowing transactions0.00
Long-term debt - borrowings17,974.00
Long-term debt - repayments-2,000.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-1,503.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net-60.00
Other net0.00
Dividends paid to minority interests0.00
Dividends paid-9,227.00
Net Cash Flow from Financing Activities2,685.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow13,983.00
Total Cash Flow5,545.00
4 historic quarters locked

Sign in to unlock the full Abbvie Inc cash flow history.

Sign In Create Free Account

About Abbvie Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001551152-26-000037

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API Connect Your AI